Research ArticleArticles
Optimizing Use of Tumor Necrosis Factor Inhibitors in the Management of Immune-Mediated Inflammatory Diseases
BRIAN BRESSLER, BOULOS HARAOUI, EDWARD KEYSTONE and ALESSANDRO SETTE
The Journal of Rheumatology Supplement May 2010, 85 40-52; DOI: https://doi.org/10.3899/jrheum.091464
BRIAN BRESSLER
BOULOS HARAOUI
EDWARD KEYSTONE
REFERENCES
- 1.↵
- Hyrich KL,
- Lunt M,
- Watson KD,
- Symmons DP,
- Silman AJ
- 2.↵
- 3.↵
- 4.↵
- Duclos M,
- Gossec L,
- Ruyssen-Witrand A,
- Salliot C,
- Luc M,
- Guignard S,
- et al.
- 5.↵
- Pincus T,
- Yazici Y,
- van Vollenhoven R
- 6.↵
- Flendrie M,
- Creemers MCW,
- Welsing PMJ,
- den Broeder AA,
- van Riel PLCM
- 7.↵
- Zink A,
- Listing J,
- Kary S,
- Ramlau P,
- Stoyanova-Scholz M,
- Babinsky K,
- et al.
- 8.↵
- 9.↵
- Stern R,
- Wolfe F
- 10.↵
- Weinblatt M,
- Genovese M,
- Bathon J,
- Kremer J,
- Fleischmann R,
- Schiff M,
- et al.
- 11.↵
- Weinblatt ME,
- Keystone EC,
- Furst DE,
- Kavanaugh AF,
- Perez JL,
- Segurado OG
- 12.↵
- 13.↵
- 14.↵
- 15.↵
- 16.↵
- 17.↵
- 18.↵
- 19.↵
- 20.↵
- Saad AA,
- Ashcroft DM,
- Watson KD,
- Hyrich KL,
- Noyce PR,
- Symmons DP,
- British Society for Rheumatology Biologics Register
- 21.↵
- 22.↵
- 23.↵
- 24.↵
- 25.↵
- 26.↵
- 27.↵
- 28.↵
- 29.↵
- Anderson PJ
- 30.↵
- van der Laken CJ,
- Voskuyl AE,
- Roos JC,
- Stigter van Walsum M,
- de Groot ER,
- Wolbink G,
- et al.
- 31.↵
- Haraoui B,
- Cameron L,
- Ouellet M,
- White B
- 32.↵
- van de Putte LB,
- Atkins C,
- Malaise M,
- Sany J,
- Russell AS,
- van Riel PL,
- et al.
- 33.↵
- 34.↵
- Centocor, Inc
- 35.↵
- 36.↵
- Bartelds GM,
- Wijbrandts CA,
- Nurmohamed MT,
- Stapel S,
- Lems WF,
- Aarden L,
- et al.
- 37.↵
- Weinblatt ME,
- Keystone EC,
- Furst DE,
- Moreland LW,
- Weisman MH,
- Birbara CA,
- et al.
- 38.↵
- Abbott Laboratories Ltd
- 39.↵
- 40.↵
- 41.↵
- Klareskog L,
- Wajdula J,
- Baker P,
- Fatenejad S
- 42.↵
- 43.↵
- 44.↵
- 45.↵
- Maini RN,
- Breedveld FC,
- Kalden JR,
- Smolen JS,
- Davis D,
- Macfarlane JD,
- et al.
- 46.↵
- 47.↵
- 48.↵
- 49.↵
- 50.↵
- Hyrich KL,
- Watson KD,
- Silman AJ,
- Symmons DP,
- British Society for Rheumatology Biologics Register
- 51.↵
- Kristensen LE,
- Kapetanovic MC,
- Gülfe A,
- Söderlin M,
- Saxne T,
- Geborek P
- 52.↵
- Gulfe A,
- Kristensen LE,
- Geborek P
- 53.↵
- Agarwal SK,
- Glass RJ,
- Shadick NA,
- Coblyn JS,
- Anderson RJ,
- Maher NE,
- et al.
- 54.↵
- 55.↵
- 56.↵
- 57.↵
- 58.↵
- Rudwaleit M,
- Claudepierre P,
- Wordsworth P,
- Cortina EL,
- Sieper J,
- Kron M,
- et al.
- 59.↵
- Miceli-Richard C,
- Comets E,
- Verstuyft C,
- Tamouza R,
- Loiseau P,
- Ravaud P,
- et al.
- 60.↵
- Padyukov L,
- Lampa J,
- Heimbürger M,
- Ernestam S,
- Cederholm T,
- Lundkvist I,
- et al.
- 61.↵
- 62.↵
- Oliveira RDR,
- Fontana V,
- Junta CM,
- et al.
- 63.↵
- 64.↵
- Nalysnyk L,
- Xu Y,
- Williams K,
- Sharma S,
- Villanueva I,
- Sallerin V,
- et al.
- 65.↵
- Bombardieri S,
- Ruiz AA,
- Fardellone P,
- Geusens P,
- McKenna F,
- Unnebrink K,
- et al.
- 66.↵
- Villeneuve E,
- Haraoui B
- 67.↵
- 68.↵
- Smolen J,
- Kay J,
- Doyle MK,
- Landewé R,
- Matteson EL,
- Wollenhaupt J,
- et al.
- 69.↵
- Hyrich KL
- 70.↵
- Silman A,
- Symmons D,
- Scott DG,
- Griffiths I
- 71.↵
- Askling J,
- Fored CM,
- Geborek P,
- Jacobsson LT,
- van Vollenhoven R,
- Feltelius N,
- et al.
- 72.↵
- Kroesen S,
- Widmer AF,
- Tyndall A,
- Hasler P
- 73.↵
- 74.↵
- 75.↵
- Dixon WG,
- Hyrich KL,
- Watson KD,
- Lunt M,
- Symmons DP
- 76.↵
- 77.↵
- Yamada T,
- Alpers DH,
- Laine L,
- Owyang C,
- Powell DW
- Greenberg HB,
- Matsui SM,
- Holodniy M
- 78.↵
- Feldman M,
- Friedman LS,
- Sleisenger MH
- Hamer DH,
- Gorbach SL
- 79.↵
- 80.↵
- Gomez-Reino JJ,
- Carmona L,
- Valverde VR,
- Mola EM,
- Montero MD,
- BIOBADASER Group
- 81.↵
- 82.↵
- 83.↵
- Calabrese LH,
- Zein N,
- Vassilopoulos D
- 84.↵
- 85.↵
- 86.↵
- De Rycke L,
- Baeten D,
- Kruithof E,
- Van den Bosch F,
- Veys EM,
- De Keyser F
- 87.↵
- De Rycke L,
- Baeten D,
- Kruithof E,
- Van den Bosch F,
- Veys EM,
- De Keyser F
- 88.↵
- 89.↵
- 90.↵
- 91.↵
- 92.↵
- 93.↵
- 94.↵
- 95.↵
- Harrison MJ,
- Dixon WG,
- Watson KD,
- King Y,
- Groves R,
- Hyrich KL,
- et al.
- 96.↵
- 97.↵
- 98.↵
- 99.↵
- Fleischmann R,
- Baumgartner SW,
- Weisman MH,
- Liu T,
- White B,
- Peloso P
- 100.↵
- Al Saieg N,
- Luzar MJ
- 101.↵
- 102.↵
- 103.↵
- 104.↵
- Franklin J,
- Lunt M,
- Bunn D,
- Symmons D,
- Silman A
- 105.↵
- 106.↵
In this issue
Optimizing Use of Tumor Necrosis Factor Inhibitors in the Management of Immune-Mediated Inflammatory Diseases
BRIAN BRESSLER, BOULOS HARAOUI, EDWARD KEYSTONE, ALESSANDRO SETTE
The Journal of Rheumatology Supplement May 2010, 85 40-52; DOI: 10.3899/jrheum.091464